These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2661626)

  • 1. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?
    Surawicz B
    J Am Coll Cardiol; 1989 Jul; 14(1):172-84. PubMed ID: 2661626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced torsade de pointes.
    Raehl CL; Patel AK; LeRoy M
    Clin Pharm; 1985; 4(6):675-90. PubMed ID: 2416504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.
    Shah SA; Kluger J; White CM
    Pharmacotherapy; 2007 Sep; 27(9):1297-305. PubMed ID: 17723083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
    Eckardt L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous sequences of onset of torsade de pointes in patients with acquired prolonged repolarization: quantitative analysis of Holter recordings.
    Locati EH; Maison-Blanche P; Dejode P; Cauchemez B; Coumel P
    J Am Coll Cardiol; 1995 Jun; 25(7):1564-75. PubMed ID: 7539014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
    Hii JT; Wyse DG; Gillis AM; Duff HJ; Solylo MA; Mitchell LB
    Circulation; 1992 Nov; 86(5):1376-82. PubMed ID: 1423949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
    Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
    J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torsade de pointes and other pause-induced ventricular tachycardias: the short-long-short sequence and early afterdepolarizations.
    Cranefield PF; Aronson RS
    Pacing Clin Electrophysiol; 1988 Jun; 11(6 Pt 1):670-8. PubMed ID: 2456546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR; Fromm BS; Steinman RT; Meissner MD; Lehmann MH
    JAMA; 1993 Dec; 270(21):2590-7. PubMed ID: 8230644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.
    Davidenko JM; Cohen L; Goodrow R; Antzelevitch C
    Circulation; 1989 Mar; 79(3):674-86. PubMed ID: 2917391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinidine-induced long QTU interval and torsade de pointes: role of bradycardia-dependent early afterdepolarizations.
    el-Sherif N; Bekheit SS; Henkin R
    J Am Coll Cardiol; 1989 Jul; 14(1):252-7. PubMed ID: 2738268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further observations to elucidate the role of interventricular dispersion of repolarization and early afterdepolarizations in the genesis of acquired torsade de pointes arrhythmias: a comparison between almokalant and d-sotalol using the dog as its own control.
    Verduyn SC; Vos MA; van der Zande J; Kulcsàr A; Wellens HJ
    J Am Coll Cardiol; 1997 Nov; 30(6):1575-84. PubMed ID: 9362418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
    Yamamoto H; Bando S; Nishikado A; Hamai K; Yamamoto K; Shinohara A
    Kokyu To Junkan; 1991 Mar; 39(3):261-5. PubMed ID: 2047605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Torsade de pointes" tachycardia. Re-entry or focal activity?
    D'Alnoncourt CN; Zierhut W; Blüderitz B
    Br Heart J; 1982 Sep; 48(3):213-6. PubMed ID: 7104111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drugs and torsade de pointes.
    Lazzara R
    Eur Heart J; 1993 Nov; 14 Suppl H():88-92. PubMed ID: 8293758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in patients with previous drug-mediated torsade de pointes. Long-term safety and efficacy.
    Mattioni TA; Zheutlin TA; Sarmiento JJ; Parker M; Lesch M; Kehoe RF
    Ann Intern Med; 1989 Oct; 111(7):574-80. PubMed ID: 2774388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.
    Verduyn SC; Vos MA; van der Zande J; van der Hulst FF; Wellens HJ
    Cardiovasc Res; 1997 Jun; 34(3):453-63. PubMed ID: 9231028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detailed analysis of 24 hour ambulatory electrocardiographic recordings during ventricular fibrillation or torsade de pointes.
    Lewis BH; Antman EM; Graboys TB
    J Am Coll Cardiol; 1983 Sep; 2(3):426-36. PubMed ID: 6192159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time- and rate-dependent alterations of the QT interval precede the onset of torsade de pointes in patients with acquired QT prolongation.
    Gilmour RF; Riccio ML; Locati EH; Maison-Blanche P; Coumel P; Schwartz PJ
    J Am Coll Cardiol; 1997 Jul; 30(1):209-17. PubMed ID: 9207644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.
    Vos MA; Verduyn SC; Gorgels AP; Lipcsei GC; Wellens HJ
    Circulation; 1995 Feb; 91(3):864-72. PubMed ID: 7828315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.